UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

 

Date of Report (Date of Earliest Event Reported):

 

June 20, 2018

 

Aspen Aerogels, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)

 

 

 

 

Delaware

001-36481

04-3559972

_____________________
(State or other jurisdiction

_____________
(Commission

______________
(I.R.S. Employer

of incorporation)

File Number)

Identification No.)

  

 

 

30 Forbes Road, Building B, Northborough, Massachusetts

 

01532

_________________________________
(Address of principal executive offices)

 

___________
(Zip Code)

 

 

 

Registrant’s telephone number, including area code:

 

(508) 691-1111

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company [ X ]

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ X ]

 


 

Item 5.07 Submission of Matters to a Vote of Stockholders

(a) On June 20, 2018, Aspen Aerogels, Inc. (the “Company”) held its 2018 annual meeting of stockholders (the “Annual Meeting”). Of the 23,882,253 shares of common stock issued and outstanding and eligible to vote as of the record date of April 23, 2018, a quorum of 22,185,022 shares, or 92.9% of the eligible shares, was present in person or represented by proxy.

(b) The following actions were taken at the Annual Meeting:

1. The following nominees were reelected to serve on the Company’s Board of Directors as Class I Directors until the 2021 annual meeting of stockholders and until their respective successors are duly elected and qualified, based on the following votes:

 

  

 

 

 

 

 

 

 

 

 

 

 

 

Nominee

 

Votes For

 

 

Votes Withheld

 

 

Broker Non-Votes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rebecca A. Blalock

 

 

11,997,056

 

 

 

1,880,293

 

 

 

8,307,673

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Robert M. Gervis

 

 

10,685,109

 

 

 

3,192,240

 

 

 

8,307,673

 

 

 

2. The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018 was ratified, based on the following votes:  

 

 

Votes For

 

 

Votes Against

 

 

Abstentions

 

 

Broker Non-Votes

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

22,002,769

 

 

 

181,376

 

 

 

877

 

 

 

 

 

 

 

 

 

 


Top of the Form

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 Date: June 20, 2018

Aspen Aerogels, Inc.

 

By: /s/ John F. Fairbanks

 

John F. Fairbanks

                                                                                   

Title: Vice President, Chief Financial Officer and Treasurer